Jessica L Beers

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 19

Top Topics

Metastatic Renal Cell Carcinoma

Health Insurance

Drug Administration

Top Venues

Drug metabolism and disposition: the biological fate of chemicals

CPT: pharmacometrics & systems pharmacology

ACS medicinal chemistry letters

This page only lists publications with an associated author ORCID identifier.

Publications

Jessica L Beers, Zhu Zhou, Klarissa D Jackson
Advances and Challenges in Modeling Cannabidiol Pharmacokinetics and Hepatotoxicity. Drug metabolism and disposition: the biological fate of chemicals 52 (6) (2024)
Lixuan Qian, Jessica L Beers, Klarissa D Jackson, Zhu Zhou
CBD and THC in Special Populations: Pharmacokinetics and Drug-Drug Interactions. Pharmaceutics 16 (4) (2024)
Jessica L Beers, Zhu Zhou, Klarissa D Jackson
Advances and Challenges in Modeling Cannabidiol Pharmacokinetics and Hepatotoxicity. Drug metabolism and disposition: the biological fate of chemicals 52 (6) (2024)
Jessica L Beers, Zhu Zhou, Klarissa D Jackson
Advances and Challenges in Modeling Cannabidiol Pharmacokinetics and Hepatotoxicity. Drug metabolism and disposition: the biological fate of chemicals 52 (6) (2024)
Lixuan Qian, Jessica L Beers, Klarissa D Jackson, Zhu Zhou
CBD and THC in Special Populations: Pharmacokinetics and Drug-Drug Interactions. Pharmaceutics 16 (4) (2024)
Lixuan Qian, Jessica L Beers, Klarissa D Jackson, Zhu Zhou
CBD and THC in Special Populations: Pharmacokinetics and Drug-Drug Interactions. Pharmaceutics 16 (4) (2024)
Jessica L Beers, Zhu Zhou, Klarissa D Jackson
Advances and Challenges in Modeling Cannabidiol Pharmacokinetics and Hepatotoxicity. Drug metabolism and disposition: the biological fate of chemicals 52 (6) (2024)
Jessica L Beers, Zhu Zhou, Klarissa D Jackson
Advances and Challenges in Modeling Cannabidiol Pharmacokinetics and Hepatotoxicity. Drug metabolism and disposition: the biological fate of chemicals 52 (6) (2024)
Jessica L Beers, Zhu Zhou, Klarissa D Jackson
Advances and Challenges in Modeling Cannabidiol Pharmacokinetics and Hepatotoxicity. Drug metabolism and disposition: the biological fate of chemicals (2024)
Jessica L Beers, Zhu Zhou, Klarissa D Jackson
Advances and Challenges in Modeling Cannabidiol Pharmacokinetics and Hepatotoxicity. Drug metabolism and disposition: the biological fate of chemicals (2024)
Lixuan Qian, Jessica L Beers, Klarissa D Jackson, Zhu Zhou
CBD and THC in Special Populations: Pharmacokinetics and Drug-Drug Interactions. Pharmaceutics 16 (4) (2024)
Jessica L Beers, Aurora K Authement, Nina Isoherranen, Klarissa D Jackson
Cytosolic Enzymes Generate Cannabinoid Metabolites 7-Carboxycannabidiol and 11-Nor-9-carboxytetrahydrocannabinol. ACS medicinal chemistry letters 14 (5) (2023)
Cindy H T Yeung, Jessica L Beers, Klarissa D Jackson, Andrea N Edginton
Verifying in vitro-determined enzyme contributions to cannabidiol clearance for exposure predictions in human through physiologically-based pharmacokinetic modeling. CPT: pharmacometrics & systems pharmacology 12 (3) (2023)
Cindy H T Yeung, Jessica L Beers, Klarissa D Jackson, Andrea N Edginton
Verifying in vitro-determined enzyme contributions to cannabidiol clearance for exposure predictions in human through physiologically-based pharmacokinetic modeling. CPT: pharmacometrics & systems pharmacology 12 (3) (2023)
Jessica L Beers, Aurora K Authement, Nina Isoherranen, Klarissa D Jackson
Cytosolic Enzymes Generate Cannabinoid Metabolites 7-Carboxycannabidiol and 11-Nor-9-carboxytetrahydrocannabinol. ACS medicinal chemistry letters 14 (5) (2023)
Elizabeth A Burnham, Arsany A Abouda, Jennifer E Bissada, Dasean T Nardone-White, Jessica L Beers, Jonghwa Lee, Matthew J Vergne, Klarissa D Jackson
Interindividual Variability in Cytochrome P450 3A and 1A Activity Influences Sunitinib Metabolism and Bioactivation. Chemical research in toxicology 35 (5) (2022)
Cindy H T Yeung, Jessica L Beers, Klarissa D Jackson, Andrea N Edginton
Verifying in vitro-determined enzyme contributions to cannabidiol clearance for exposure predictions in human through physiologically-based pharmacokinetic modeling. CPT: pharmacometrics & systems pharmacology (2022)
Boris Reidel, Sabri Abdelwahab, Joe Alexander Wrennall, Phillip W Clapp, Jessica L Beers, Klarissa D Jackson, Robert Tarran, Mehmet Kesimer
Vaping additives cannabinoid oil and vitamin E acetate adhere to and damage the human airway epithelium. Journal of applied toxicology : JAT (2022)
Cindy H T Yeung, Jessica L Beers, Klarissa D Jackson, Andrea N Edginton
Verifying in vitro-determined enzyme contributions to cannabidiol clearance for exposure predictions in human through physiologically based pharmacokinetic modelling. CPT: pharmacometrics & systems pharmacology (2022)